Menu
MapConnectionsTopicsBulgariaThe Night (K-TRIO)Marie Skłodowska-CurieFor studentsFor teachersMethodologySurprise me
HECOFUND2023–2028

AECC Talent · FCAECC Fellowship programme for talented researchers in cancer

Horizon Europe — Marie Skłodowska-Curie Actions

Duration
2023-09-01 → 2028-08-31
EU contribution
€4,298,400
Participants
30
Scheme
HORIZON-TMA-MSCA-Cofund-P

Lines connect the coordinator with its partners.

Results in brief

FCAECC Fellowship programme for talented researchers in cancer

Cancer is one of the most significant health challenges worldwide, and the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) is the leading private philanthropic entity funding cancer research in Spain. With a strong commitment to excellence, FCAECC currently supports over 750 research projects with a total investment of 143 million EUR, contributing to high-impact scientific output and improved patient outcomes. To further strengthen Spain’s position in global cancer research, FCAECC has launched AECC Talent, a fellowship programme aimed at attracting experienced international researchers. This initiative supports transnational mobility and aligns with the Horizon Europe Mission on Cancer, focusing on key areas such as prevention, early diagnosis, monitoring, and treatment. AECC Talent will fund up to 30 fellowships across two calls, offering researchers the opportunity to join one of the accredited host organisations known for their excellence and international collaboration. Fellows will be able to develop their own research lines within multidisciplinary teams, contributing to both scientific advancement and societal benefit. By integrating global talent into Spain’s research ecosystem, AECC Talent is expected to accelerate innovation, enhance collaboration, and improve outcomes for cancer patients, reinforcing Spain’s leadership in cancer research at both national and international levels.

Data: CORDIS, © European Union

Project objective

The Scientific Foundation of the Spanish Association against Cancer (from now on, FCAECC) is a philanthropic private entity that aims to finance excellent cancer research in Spain for the benefit of the general public and patients. Ranging from basic research to clinical application, FCAECC is the entity that devotes the most funds to promote and support cancer research in Spain. In its Strategic Plan, FCAECC states its firm commitment to finance the best cancer research in Spain, aiming at promoting talent, stabilizing the professional career of researchers, fostering the globalization of Spanish cancer research and involving society. FCAECC has a national fellowship programme that supports experienced researchers to develop their own research lines and currently is funding 525 cancer research projects worth 92 million EUR, which resulted in 316 publications in 2021, with an average impact factor of 8.With AECC Talent new fellowship programme, FCAECC opens its fellowship programme for trans-national mobility, aiming to attract to Spain the most talented experienced researchers from abroad. AECC Talent will contribute to improve prevention, early diagnosis, monitoring and treatment of cancer patients, which are key intervention areas of the Horizon Europe Mission on Cancer. AECC Talent will fund 30 fellowships divided into two calls.Host organisations participating in the programme are accredited by FCAECC as excellent in cancer research by means of a rigorous assessment process that guarantees their quality, impact and leadership in cancer research at national and international level. Fellows will have a wide choice of entities and multidisciplinary teams in which to carry out the project of their interest, following a bottom-up approach. The 15 host organisations report a high number of international collaborations and participation in European and international projects and endorse the principles of the Charter & Code for Researchers.

Original text from CORDIS.

Participants

  • FUNDACION CIENTIFICA DE LA ASOCIACIÓN ESPANOLA CONTRA EL CANCER · MadridCoordinatorSpain
  • ADVANCED MARKER DISCOVERY SL · VALLADOLIDSpain
  • APPLIED RESEARCH USING OMIC SCIENCES SL · BarcelonaSpain
  • ASOCIACION ESPANOLA DE BIOEMPRESAS · MADRIDSpain
  • Asociación Española de Investigación Sobre el Cáncer · BarcelonaSpain
  • BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED, VEREJNA VYSKUMNA INSTITUCIA · BratislavaSlovakia
  • DANA-FARBER CANCER INSTITUTE INC · Boston MaUnited States
  • DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG · HeidelbergGermany
  • EUROPEAN ASSOCIATION FOR CANCER RESEARCH · NOTTINGHAMUnited Kingdom
  • Elzaburu, S.L.P. · MadridSpain
  • FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI · MilanItaly
  • FUNDACIO CENTRE DE REGULACIO GENOMICA · BarcelonaSpain
  • FUNDACION ESPANOLA DE ONCOLOGIA RADIOTERAPICA · MADRIDSpain
  • FUNDACION ESPANOLA PARA LA CIENCIAY LA TECNOLOGIA, F.S.P., FECYT · AlcobendasSpain
  • Fundacion Kertor · Santiago De CompostelaSpain
  • Gesellschaft zur Förderung der Lebenswissenschaften Heidelberg GmbH · HeidelbergGermany
  • HIGHLIGHT THERAPEUTICS SL · VALENCIASpain
  • INSTITUT GUSTAVE ROUSSY · VillejuifFrance
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE · ParisFrance
  • Indian Association for Cancer Research · ThiruvananthapuramIndia
  • KAROLINSKA INSTITUTET · STOCKHOLMSweden
  • KOBENHAVNS UNIVERSITET · KOBENHAVNDenmark
  • MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV · MUNCHENGermany
  • MIWENDO SOLUTIONS SL · BarcelonaSpain
  • National Cancer Center · GoyangSouth Korea
  • ONENA MEDICINES SL · SAN SEBASTIANSpain
  • SCIENSEED SL · MADRIDSpain
  • Sociedad Española de Oncología Médica (SEOM) · MadridSpain
  • UNIVERSIDADE DE AVEIRO · AveiroPortugal
  • UNIVERSITAETSKLINIKUM AACHEN · AachenGermany

Links

Data: CORDIS, © European Union